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Tumor suppressor p53 regulates transcription of
stress-response genes. Many p53 targets remain un-
discovered because of uncertainty as to where p53
binds in the genome and the fact that few genes
reside near p53-bound recognition elements (REs).
Using chromatin immunoprecipitation followed by
exonuclease treatment (ChIP-exo), we associated
p53 with 2,183 unsplit REs. REs were positionally
constrained with other REs and other regulatory
elements, which may reflect structurally organized
p53 interactions. Surprisingly, stress resulted in
increased occupancy of transcription factor IIB
(TFIIB) and RNA polymerase (Pol) II near REs, which
was reduced when p53 was present. A subset asso-
ciated with antisense RNA near stress-response
genes. The combination of high-confidence loca-
tions for p53/REs, TFIIB/Pol II, and their changes in
response to stress allowed us to identify 151 high-
confidence p53-regulated genes, substantially
increasing the number of p53 targets. These genes
composed a large portion of a predefined DNA-
damage stress-response network. Thus, p53 plays
a comprehensive role in regulating the stress-
response network, including regulating noncoding
transcription.INTRODUCTION
p53, the ‘‘guardian’’ of the genome, is a sequence-specific tran-
scription factor that, along with other factors, regulates genes
involved in stress responses such as UV-induced DNA damage
(Menendez et al., 2009; Ptashne and Gann, 1997; Riley et al.,514 Cell Reports 8, 514–527, July 24, 2014 ª2014 The Authors2008). p53 is one of themost commonlymutated proteins in can-
cers (Donehower and Bradley, 1993). Knowing exactly where
p53 binds across a genome, which genes it regulates and
how, has been a critical limitation in defining p53’s protective
functions. Indeed, the current set of p53 targets does not fully
explain p53’s protective effects (Ma, 2011). Dysfunction of p53
has largely been attributed to defects in p53’s DNA binding sur-
face (Freed-Pastor and Prives, 2012; Vogelstein and Kinzler,
1992). However, mutations in a p53 recognition element (RE)
could also impair p53’s ability to regulate its target gene (Ban-
dele et al., 2011; Naqvi et al., 2010), and this has been largely re-
fractory to study due to the uncertainty of precisely where p53
binds in a genome.
Thousands of putative p53-bound locations have been re-
ported across the human genome (Botcheva et al., 2011; Cawley
et al., 2004; Menendez et al., 2013; Nikulenkov et al., 2012;
Schlereth et al., 2013; Smeenk et al., 2011; Smeenk et al.,
2008; Wang et al., 2014; Wei et al., 2006; Yu et al., 1999; Zhao
et al., 2000). However, confidence in such locations is limited
by assay sensitivity (signal:noise) that tends to detect the most
highly occupied regions and assay resolution having positional
uncertainty of several hundred base pairs rather than pinpointing
its exact location. Importantly, current RE descriptions lack suf-
ficient uniqueness to confidently identify all but the most robust
REs. For example, a recent chromatin immunoprecipitation
sequencing (ChIP-seq) study predicted an RE in only half of all
743 high-confidence p53 ChIP-seq peaks (Botcheva et al.,
2011).
A p53 RE is comprised of two 10 bp half-sites that have the
highly degenerate consensus sequence (RRRCWWGYYY)2,
where RWY = A/G, A/T, and C/T, respectively. However, devia-
tions from this consensus are common, and REs reportedly
tolerate 1–13 bp insertions between each half-site, deletion of
half-sites, and RRRCW quarter sites in multiple orientations (el-
Deiry et al., 1992; Funk et al., 1992; Riley et al., 2008). These
criteria, if correct, allow for many millions of potential REs across
a genome. Because p53 binding may be enriched in
nucleosomal regions (Lidor Nili et al., 2010), invoking chromatin
occlusion of REs does not provide an adequate explanation as
to the restriction of p53 binding to only a small fraction of putative
sites. Thus, a comprehensive, as opposed to statistically en-
riched, genome-wide identification of p53-bound REs has not
yet been achieved.
A general paradigm is that p53 mainly regulates protein-
coding genes as both a local core promoter factor and as
part of a long-distance enhancer (Riley et al., 2008; Thut
et al., 1995). The notion of an enhancer being far from the
gene (or transcription unit) that it regulates has been clouded
by the discovery of enhancer RNAs (eRNAs), which are pro-
duced near enhancers (Kim et al., 2010; Ørom and Shiekhattar,
2013). Although eRNAs tend to be nonpolyadenylated, capped
and polyadenylated forms also exist (Djebali et al., 2012).
Recently, two p53-bound enhancers were shown to produce
eRNAs locally that regulate a more distal coding gene (Melo
et al., 2013). However, it remains unclear whether transcription
in the vicinity of p53 REs is common and whether such events
are regulated.
Here, we use chromatin immunoprecipitation followed by
exonuclease treatment (ChIP-exo) (Rhee and Pugh, 2011) to pre-
cisely and more accurately map the genomic locations of p53
binding in response to a variety of genotoxic stresses. ChIP-
exo is a refinement of ChIP-seq that produces high accuracy
and sensitivity. From this, we characterize the surrounding
DNA sequence and target genes. To investigate potential tran-
scription events in the vicinity of p53, we mapped transcription
factor IIB (TFIIB) and polymerase (Pol) II by ChIP-exo, measured
RNA, and examined their function at select model genes, all in
response to a variety of stresses (UV light, nutlin, doxorubicin,
and 5-fluorouracil). Together, these findings uncover a pervasive
and comprehensive network of coding and noncoding transcrip-
tion that is stress induced and p53 regulated. Collectively, these
results implicate p53 in playing a broader role in ‘‘guarding’’ the
genome.
RESULTS
Detection of 2,183 p53-Bound REs
We first examined p53 binding in U2OS cells 6 hr after UV treat-
ment, which we confirmed to induce signatures of apoptosis
and responses to DNA damage (Figure S1A). Later in the study,
we also employed other p53-activating agents (Figure S1B).
The distribution of p53 ChIP-exo tags (50 ends) under condi-
tions of UV stress for all candidate locations is shown in Fig-
ure 1A. To achieve comprehensive coverage while maximizing
accuracy (Table S1), we implemented a bioinformatic valida-
tion/filtration approach to ferret out false positives (Figure S1C).
Remarkably, 90% of all locations were validated as having a
20 bp unsplit RE, which included 4% having a 1 bp spacer. The
false discovery rate was <5%, determined by scrambling the
motif or the search space. A triple peak pair pattern was
evident around the REs (Figure 1B). Each peak pair corre-
sponded to a p53/RE half-site border (Figure 1B, upper dia-
gram), with the central peak pair reflecting the adjoining internal
borders between adjacent half-sites. This pattern reflects on a
genomic scale the crystallographic structure of p53 as a dimerof dimers (Kitayner et al., 2006; Tidow et al., 2007) and offers
a potential diagnostic signature for p53 binding across a
genome.
When all examined stresses were considered, 2,183 p53-
bound REs were found. More may remain undetected in other
cell types or responses. Consistent with prior reports of induc-
ibility of p53 binding (Ceribelli et al., 2006; Espinosa et al.,
2003; Kaeser and Iggo, 2002; Shaked et al., 2008), about half
of all p53 locations had a >2-fold change in occupancy in at least
three of the four stresses (Figure 1C; Table S1, which allows
occupancy thresholds to be adjusted). Thus, about half of p53-
bound REs appear to be activated via a general stress response,
which is consistent with the concept of a core default response
(Nikulenkov et al., 2012). About 30% were specific to two
stresses, and 15% were specific to either 5-fluorouracil or UV
treatment. Both nutlin and doxorubicin elicited a general
response but little or no detectable stress-type-specific
response. This was also apparent at higher fold change thresh-
olds (Figure S1D) and, thus, differs from a prior conclusion that
there may only be a single default response (which was defined
in a different cell line) (Nikulenkov et al., 2012). Moreover, nutlin
and doxorubicin were not entirely identical, which is in accord
with a prior report by Menendez et al. (2013).
As expected, the set of ChIP-exo locations determined under
UV stress substantially overlapped with nine preexisting data
sets of locations determined by ChIP-chip, ChIP paired-end
tags, and ChIP-seq (Figures S1E and S1F). However, about
36%–95% of prior locations were not found in our UV-induced
data set, and similar percentages were missed. The number of
locations identified here and in other studies is subject to differ-
ences in cell types, stress treatments, levels of nonspecific DNA
contamination, assay variables such as PCR amplification, and
data thresholding, all of which places substantial limits on the
generalization of conclusions drawn.
RE Sequences Are Degenerate, Unsplit, and Spatially
Organized in the Genome
Only 162 (10%) of all p53-boundREsdetected inU2OScells con-
tained an exact match to an already degenerate 20 bp full RE
consensus (RRRCWWGYYYRRRCWWGYYY), thereby preclud-
ing effective ab initio site identification without having measured
binding locations. p53-bound REs typically contained one half-
site that matched the consensus (Figure 1A) and a second half-
site that deviated from the consensus by a limited degree. This
observation fits with prior studies by el-Deiry et al. (1992) and
Funk et al. (1992) and with the notion that p53 initiates binding
at one half-site then completes binding at a second half-site
(McLureandLee, 1998). p53wasnot appreciably detectedat iso-
lated half-sites and, thus, may only stably bind full sites in vivo.
Binding was the lowest, but also the most inducible, at weak
REs (Figures 2A and S2A). Deviations from the consensus
quarter site (R1R2R3CW) followed the trend: R1 > R2 > R3 =
W > C, with the central two quarter sites being somewhat less
variable for their respective half-sites (Figures 2B and S2B).
Therefore, basal and constitutive p53 site occupancy may be
tuned in part through variations from the consensus.
Although p53 is thought to bind REs that contain 1–13 bp in-
sertions between their half-sites (el-Deiry et al., 1992; FunkCell Reports 8, 514–527, July 24, 2014 ª2014 The Authors 515
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Figure 2. Genome-wide Characteristics of
p53/RE Interactions
(A) Relationship between p53 site quality and oc-
cupancy level. U2OS group 1P sites (n = 1,452)
were binned according to occupancy levels (per-
centages) in uninduced cells, then color coded
according to site quality (according to Menendez
et al., 2009). Blue is further from the consensus.
(B) Base composition at each position in an RE
quarter site (RRRCW), separated out by occu-
pancy levels (percent ranks) in uninduced control
U2OS cells.
(C) Frequency distribution of pairwise distance
between p53-bound REs. A total of 2,129 REs in
1,571 group 1 regions were subjected to auto-
correlation analysis.
(D) Frequency distribution of pairwise distance
between p53-occupied regions. A total of 1,571
group 1 regions were subjected to autocorrelation
analysis. Multiple REs in a region were treated as a
single location. Data were binned in 20 bp intervals
and smoothed using a three-bin moving average.
A total of 40 paired regions were <600 bp apart.et al., 1992; Jordan et al., 2008; Qian et al., 2002; Riley et al.,
2008), these events were rare (n = 67; Table S1) and could be ex-
plained by weak unsplit sites that overlap with seemingly stron-
ger but erroneous split sites (Figures S2C andS2D).We therefore
conclude that p53 tetramers bind only to unsplit REs.
A large number of closely spaced REs overlapped by 10 bp
(n = 267 pairs; Figure 2C). This affords p53 with two binding sites
at the cost of evolving three half-sites. Overlapping sites had the
same distribution of sequence quality as nonoverlapping sites
(data not shown) but tended to be constitutively occupied (Fig-
ure S2E). A second mode of RE site clustering was observedFigure 1. Comprehensive Identification of p53-Bound REs in UV-Treated U2OS Cells
(A) Distribution of 50 ends of p53 ChIP-exo sequencing tags around all 1,824 enriched regions (rows) detected
three groups, having (1) two RE half-sites with no insertion (n = 1,571), (2) two putative RE half-sites with 1–13 b
(n = 107). REs are oriented to have the stronger consensus half-site to the left. Data are normalized to a globa
panels and sorted by fold change in p53 occupancy. The third panel displays the DNA sequences encompass
The fourth panel reports only deviations from the consensus, using the same color code as in panel 3. The fift
specific colors. The far-right panels report half- or full site quality, as a whole, based on transactivation pote
(B) Composite distribution of the locations of p53 ChIP-exo peaks for Group 1, distributed around RE midpoin
model shows an interpretation of the ChIP-exo peak pattern. In a population of p53/RE tetramer complexes, c
between dimers. Because crosslinking is incomplete, a more 50 crosslink (denoted by ‘‘X’’) does not nece
population-based analysis.
(C) Venn diagram of p53 binding locations responding to stress (at least 2-fold occupancy change).
Cell Reports 8, 514–with an 250 bp separation (Figure 2D).
Thus, p53-bound REs have both a local
and a distal positional relationship with
themselves.
Binding Sites for p53 and Other
Cellular Factors Have Positional
Relationships
Because p53 interacts with sequence-
specific transcription regulators and the
core transcription machinery (Laptenko
and Prives, 2006), we expected to detectp53 crosslinking to other proteins bound at their cognate DNA
sites. But this was not observed. We therefore searched for
DNAmotifs that co-occurred with REs as one indicator of factors
that might work positively or negatively with p53 locally. Several
motifs were not only enriched near p53 REs, but many peaked at
fixed distances and had a fixed orientation relative to the REs
(Figures 3 and S3A). For example, p53-bound REs displayed a
peak of enrichment 30 bp 30 to the GATA1 motif, WGATAR,
thereby implicating at least one GATA family member in coregu-
lation with p53. Other positional relationships included factors
involved in environmental stress and oncogenesis, such asin untreated or UV-treated U2OS cells. Data are in
p insertion or 1 bp deletion (n = 146), or (3) all others
l constant background. Rows are linked across all
ing each RE. Group 3 used the peak pair midpoint.
h panel reports the same deviations using position-
ntial (Menendez et al., 2009).
ts and smoothed with a 3 bp moving average. The
rosslinks occur at the tetramer edge and internally
ssarily block detection of a more 30 crosslink in a
527, July 24, 2014 ª2014 The Authors 517
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Figure 3. Stress-Response Elements Have
a Spatial Relationship with REs
MEME logos of motifs statistically enriched near
the 1,571 p53-bound regions of group 1, along
with the number of occurrences. The distribution
of p53/REs around each motif (motif p < 104),
orientated according to the sequence logo, is
shown. The composite plot uses aGaussian kernel
and a smoothing bandwidth of 20. Four-color
nucleotide plots for each instance of the indicated
motifs (GATA1 and Klf4) are shown to the right, in
which p53 REs are shaded.AP1, NRF2, FOXO3, and ETS/SPI1/PU.1, and pluripotent stem
cell maintenance, such as Oct4, Sox2, Klf4, and Myc, or related
family members. A number of these factors have been demon-
strated to have functional interrelationships with p53 (Renault
et al., 2011; Rotblat et al., 2012; Tu et al., 2009; Zhu et al.,
2006). Approximately 1,000 paired genomic features were iden-
tified (Table S2).
A substantial subset of these features exists within ancient
endogenous retroviral long terminal repeats (LTRs) (see blocks
of vertical colored stripes in the right panels of Figure 3, and
also Figure S3B), which may contribute to positional specificity.
Because AP1 and NRF2 were positionally restricted, but not en-
riched in repetitive elements, positional constraints of some ele-
ments were not necessarily a consequence of being in repetitive
elements. Moreover, element had the same orientation relative518 Cell Reports 8, 514–527, July 24, 2014 ª2014 The Authorsto REs regardless of whether it was inside
or outside of LTRs, indicating that such
constraints are not imposed by the LTR.
LTRs are among the oldest repetitive ele-
ments in the human genome, and thus,
the maintenance of factor binding sites
is likely to be important. These findings
are entirely consistent with and expand
upon the concept that endogenous
LTRs act as enhancer vehicles (Cohen
et al., 2009). Together, the distance and
orientation constraints of the motifs sug-
gest that a spatial, potentially coopera-
tive, relationship exists between many
p53/RE complexes and the factors (or
complex of factors) that bind to the iden-
tified motifs. A cooperative relationship
would reduce the dependence of p53 on
the RE sequence.
TFIIB and Pol II Are Enriched at REs
With the discovery of eRNAs and, in
particular, a recent report of two p53-
bound RE regions giving rise to eRNAs
(Melo et al., 2013), we next addressed
the generality of RE-associated transcrip-
tion in the context of all 2,183 p53-bound
REs. We performed ChIP-exo on the gen-
eral transcription initiation factor TFIIBand RNA Pol II, as well as strand-specific RNA sequencing
(RNA-seq). Remarkably, TFIIB tags were enriched at p53 REs
acrossmultiple cell lines (Figure S4). When all data weremerged,
the enrichment was evident at most p53 REs (Figure 4A). Similar
enrichments were observed for Pol II and, to a lesser extent, RNA
(Figure 4A). The occupancy levels of both TFIIB and Pol II at most
locations were similar to the average at annotated mRNA genes
(tag counts: TFIIB, 4.3/2.6/2.1; Pol II, 6.3/7.0/2.1, for RE-associ-
ated/mRNA/‘‘+100 kb’’ background, respectively, as defined in
Figures 4B and 4C).
A composite plot of TFIIB occupancy at all REs, orientated to
place the higher level of TFIIB on the same side, shows that TFIIB
was particularly enriched within 50 bp of an RE midpoint (Fig-
ure 4B). This was confirmed by the Pol II data, which was orien-
tated based on TFIIB (Figure 4C). We interpret this enrichment as
AB C
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Figure 4. p53/REs Coincide with Noncoding
Transcription Complexes
(A) Plot of p53, TFIIB, and Pol II ChIP-exo tag 50
ends around individual REs (rows). All data from
U2OS and HCT116 cells were combined. All rows
are linked, aligned by RE midpoint, plotted
from ±15 kb, and sorted by Pol II occupancy (in
the±2.5 kb region).ChIP-exodatawere normalized
to have a constant total background (not locally
normalized). Also shown are corresponding RNA-
seq tags, parsedbyDNAstrand (blue denotes 50–30
from left to right; red denotes the antiparallel
strand). RNA-seqdata fromK562andG12878cells
were added for comparison (Morozova et al.,
2009). Please note that the orientation of each pair
of DNA strands is random, which gives the false
impression of transcription bidirectionality.
(B) Composite distribution of TFIIB around 2,183
p53/REs or control regions (+1 and +100 kb from
each RE). REs were orientated to maximize TFIIB
occupancy on the right. All data sets (cell lines and
stresses) for each factor were combined.
(C) Composite distribution of Pol II, orientated as
in (B), and broken out into occupancy percent
ranks. This subdivision necessitated normalizing
the data.sites of local initiation complex assembly that are positionally
linked to p53 REs. Because <1% of p53 REs are within
100 bp of an annotated mRNA transcription start sites
(TSSs), the local p53-associated initiation complexes may pro-
duce noncoding transcription. However, whereas soluble/stable
RNA levels appear to correlate with Pol II levels over the broader
region (Figure 4A), TSS detection appeared limited to high-
occupancy initiation complexes. Therefore, it remains unclear
whether low-occupancy sites are indeed sites of initiation, as
opposed to sites of initiation complex assembly.
Stress-Induced RE-Associated Transcription
Complexes
We next examined whether RE-associated transcription com-
plex assembly was regulated by the same environmental
stresses that regulate the p53 response. Relative to unstressed
control cells and compared to an equivalent set of randomlyCell Reports 8, 514–selected annotated genes, treatment
with nutlin-3a, doxorubicin, or 5-fluoro-
uracil resulted in a substantial number of
p53 RE regions showing a >4-fold in-
crease in TFIIB and Pol II occupancy (Fig-
ure 5A). However, this was more evident
in HCT116 p53/ cells. In HCT116
p53+/+ cells, more RE regions saw a
decrease in TFIIB/Pol II occupancy in
response to stress. In U2OS cells, which
have an intermediate level of p53 (Fig-
ure S5A), an intermediate effect was
observed. Although conclusions that can
be drawn across distinct cell types may
be limited, the results suggest that a vari-ety of stresses induce local RE-associated transcription com-
plex assembly, but the levels of these complexes are generally
reduced at high levels of p53. Very different mechanisms could
explain the reduction. First, due to its proximity, p53/RE binding
might directly block assembly, although an indirect mechanism
is not excluded. Alternatively, p53/RE binding might release
the initiation complex into productive transcription thereby dissi-
pating Pol II from the region, and a loss of TFIIB. Other mecha-
nisms are not excluded. How transcription complex assembly
arises in the absence of p53 is unclear, although one suggestion
from Figure 4 is that other nearby transcription factor binding
sites and their cognate factors could fulfill this role.
The observation that nutlin treatment, like other stresses,
resulted in a substantial number of TFIIB and Pol II RE-asso-
ciated locations increasing in occupancy in the absence of
p53 (HCT116 p53/) was surprising because nutlin is
thought to block Mdm2-p53 interactions, which are absent527, July 24, 2014 ª2014 The Authors 519
AB
C D
(legend on next page)
520 Cell Reports 8, 514–527, July 24, 2014 ª2014 The Authors
in this cell line. Recent studies suggest that other Mdm2 in-
teractions are also inhibited by nutlin, independent of p53
(Kurokawa et al., 2013; Valentine et al., 2011). If true, disrup-
tion of such interactions by nutlin might promote assembly of
TFIIB/Pol II at REs.
Surprisingly, in U2OS cells, 46 RE-associated UV-induced
annotated genes (described below) produced antisense tran-
scripts (Figure 5B; Table S3), many of which were also UV
induced. These included the well-studied p21, PUMA, and
MDM2 genes (Figure S5B), which we verified by quantitative
PCR (qPCR) (Figure 5C, red bars). Other stresses also caused
antisense induction at these three genes. Antisense RNA levels
were generally greater than sense RNA levels. In HCT116 cells
having high levels of p53, the relative sense/antisense induc-
ibility was largely reversed, where sense transcription was
more highly induced. Cells lacking p53 did not display a biased
sense/antisense relationship (except at p21). These findings
suggest that at least at PUMA and MDM2, high levels of p53
may inhibit stress-induced antisense transcription and promote
sense transcription, thereby regulating sense/antisense ratios.
A similar mechanism may be in play at p21 but with additional
p53-independent contributions. Thus, p53 levels may affect the
expression of coding genes in part through effects on antisense
transcription. This assessment is based on general trends of
p53 levels occurring across distinct cancer cell lines and within
the same cell line and, thus, complicated by cell-type-specific
effects.
To directly address the role of antisense in regulating sense
expression, p21 antisense transcripts were knocked down in
U2OS cells by small interfering RNA (siRNA), then tested for
p21 sense induction by UV stress. We observed an increase in
levels of p21 protein in comparison to a scrambled siRNA control
(Figure 5D). This suggests that UV-induced p21 antisense RNA
downregulates p21 sense expression, in accord with a prior
report demonstrating that UV stress leads to reduction of p21
in preparation for apoptosis (Bendjennat et al., 2003). It also
fits with the more general notion that p53-regulated noncoding
RNA (ncRNA) promotes gene repression globally (Huarte et al.,
2010; Marı´n-Be´jar et al., 2013). Taken together, these findings
suggest a tandem repression mechanism for regulating p21
expression, where stress-induced antisense transcripts atten-
uate stress-induced sense expression. High levels of p53 may
inhibit antisense production, thereby allowing full sense gene
activation (which may also have direct contributions from p53
and other factors). How general this mechanism is remains to
be determined because not all stress-induced antisense tran-
scription is accompanied by a corresponding reduction of sense
transcription (Figure 5B).Figure 5. Impact of Stress and p53 on TFIIB and Pol II Occupancy and
(A) Number of p53/RE locations (out of 2,183) that increases or decreases in TFIIB
U2OS and HCT116 (p53/ and p53+/+) cells. Also shown is a parallel analysis w
representing the false-positive rate. Occupancy levels were first normalized to g
(B) Distribution of sense (blue) and antisense (red) RNA within 5 kb of a p53-assoc
two panels overlay sense and antisense in control and UV-treated U2OS cells, w
(C) qPCR detection of sense and antisense transcripts at three p53-regulated gen
unstressed controls. SDs are shown.
(D) Knockdown of p21 antisense transcript results in elevated p21 levels. U2OS
then subjected to mock or UV treatment. Western blotting of p21, p53, and an ap53-Associated Stress-Induced Genes
In an effort to link p53 and stress with mechanisms of gene regu-
lation, we initially narrowed in on a filtered set of 751 ‘‘active’’
genes (annotated TSSs having stringently defined TFIIB, and
also being <10 Mb from a p53-bound RE in UV-treated U2OS
cells; see Supplemental Experimental Procedures for details
and Table S4). UV treatment of U2OS cells generally had little
effect on TFIIB occupancy at these genes, which was surprising
because recruitment of initiation factors has been considered
as one basis for gene induction (Ma, 2011; Ptashne and Gann,
1997). In contrast, Pol II was released from where it normally
pauses at the 50 ends of genes and increased in gene bodies,
which is in accord with models on heat shock induction (Fig-
ureS6A) (Rougvie andLis, 1988).Wecannot exclude thepossibil-
ity that at least some of the Pol II is lost due to UV-induced degra-
dation. Related observations of Pol II releasewere reported at the
p53-regulated Fas and p21 genes (Espinosa et al., 2003; Gomes
et al., 2006), but this has not been examined on a genomic scale.
The reduction of Pol II at promoter regions generally dimin-
ished at longer p53 distances from the annotated TSS
(Figure 6A), indicating that proximity to p53 is associated with
UV-induced Pol II release from the pause region. Consistent
with the role that distance plays, only the two closest ‘‘active’’
genes to p53 REs tended to respond positively to UV stress, in
comparison to more distal genes that responded negatively (Fig-
ure 6B). Although these findings do not establish that p53 directly
participates in the pause release, and there are certainly p53-
independent UV-mediated effects on Pol II, they are consistent
with established interactions of p53 with elongation factors
(Lew et al., 2012; Shinobu et al., 1999), which include c-Myc
(Rahl et al., 2010). As noted in Figure 3, binding sites for the
pausing regulator c-Myc are organized around p53 REs.
Using the proximity assessment described above, we gener-
ated a set of 269 ‘‘active’’ annotated genes having p53 binding
within 15 kb of their TSSs but also having a lower stringency
for TFIIB occupancy (see Supplemental Experimental Proce-
dures), so as to be more inclusive of potential p53-regulated
genes. Of these, p53 was particularly enriched within 1 kb of
the TSS of 48 mRNA, 14 ncRNA, and 6 tRNA genes (Figure 6C).
These promoter-proximal p53 locations generally had REs that
deviated more from the consensus than distant REs (Figure 6D),
which is a property of more inducible REs.
Within this set of 269 genes, we identified 151 mRNA genes in
which UV treatment was linked to increases in Pol II in the body
of the gene (Figure 6E; Table S5). As demonstrated above, this
might reflect some net contribution of sense and antisense tran-
scription. Table S5 also reports hand-selected literature-curated
alternative targets, which did not meet our objective criteria forRNA Levels
or Pol II occupancy by more than 4-fold upon the indicated stress treatment in
ith randomly selected RefSeq promoter regions (typically not p53 regulated),
lobally averaged local background.
iated mRNA TSS (n = 40) that displays a sense/antisense relationship. The first
hereas the third and fourth panels show only the antisense.
es in response to stress (n = 3). Values represent fold changes in RNA relative to
cells were treated with either p21 antisense siRNA or with a scrambled siRNA,
ctin control was then performed.
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Figure 6. Properties of p53 at Annotated
Genes
(A) Fold changes in TFIIB or Pol II occupancy, upon
UV treatment in U2OS cells, are shown as a function
of distance between TFIIB/TSS locations and the
closest p53.
(B) Bar graph of changes in median Pol II occupancy
in 751 ‘‘active’’ gene bodies in response to UV
treatment in U2OS cells as a function of ranked
order distance from p53 (bottom graph). Distances
of their TFIIB/TSS locations from the nearest p53 are
indicated in the top panel.
(C) Distribution of p53-bound locations within 15 kb
of 269 annotated TSS/TFIIB locations (blue). Rows
were sorted by p53-TSS distance. Each p53 loca-
tion was color coded according to its changes in
occupancy in response to UV treatment.
(D) Site quality of p53 REs in relation to distance
from TSSs. p53-bound REs within the indicated
range of a HAVANA TSS/TFIIB location (n = 252)
were obtained, then the fraction of sites was color
coded according to site quality, as in Figure 2A.
(E) List of ‘‘active’’ p53-associated genes that
showed increased Pol II binding in their gene body
(from Table S5). Underlined genes are known to be
p53 regulated.gene activity. An additional lower-confidence set of 100 genes,
having UV-induced p53 binding >15 kb away and displaying
increased Pol II binding in the gene body, is provided in Table
S6. These were not studied further. In Table S1, we also report
the closest annotated gene (including annotated ncRNAs) to
each of the 2,183 p53/REs regardless of their transcriptional
activity. Many of these may be bona fide p53 targets but did
not meet our measured criteria of gene activity.
The 151 high-confidence genes in Table S5 include 74 previ-
ously reported p53 target genes, whereas 77 genes were not
previously identified as being linked to p53, which demonstrates
the utility of this study in identifying new transcription factor
target genes. Several new target genes include long intergenic
RNAs (lincRNAs) and transcripts of unknown function (Fig-
ure S6B). Several lincRNAs have been previously identified as522 Cell Reports 8, 514–527, July 24, 2014 ª2014 The Authorsp53 targets (Barsotti and Prives, 2010;
Huarte et al., 2010). They play a key role
in p53-mediated repression of genes on a
broad scale. The newly assigned p53
target genes are involved in a variety of
functions, including cell growth, cell cycle,
cell signaling, differentiation, apoptosis,
cell adhesion and motility, and intracellular
transportation (Figure 6E; Table S5).
p53/RE-Associated Genes Dominate
Stress Regulatory Networks
Gene network analyses found that the
DNA replication, recombination, and
repair gene network had the highest
enrichment score (p z1048) (Figure 7A).
Of the 25 genes involved in this network,10 of them are newly discovered p53 targets. The functions
of these genes implicate p53 in regulating many more steps
of the DNA-damage response after UV irradiation than previ-
ously appreciated. Of the existing and novel targets, CDKN1A,
GADD45, and PLK3 control the cell cycle, allowing time to
repair damaged DNA before the cell cycle progresses further.
XPC and DDB2 recognize damaged DNA and recruit the
DNA-damage repair complex. POLH, PCNA, and UBR5 repair
the damaged DNA. FTL and RRM2B can participate in the syn-
thesis of deoxyribonucleotides for DNA repair. Several factors
regulating p53 posttranslational modifications (e.g., PLK3,
MDM2, MTBP, and OGT) are present in this network, suggest-
ing that p53 feedback loops are activated to repair DNA dam-
age. RAD51C in the DNA-repair network is related to RAD51,
an important mediator of homologous DNA recombination
AB
Figure 7. p53 Regulatory Networks and
SNPs
(A) Known IPA (Ingenuity Pathway Analysis)
DNA-repair network of gene/protein (nodes)
interactions (edges). Nodes are colored shades
red or green to reflect fold changes (increased
and decreased, respectively) in p53 occupancy
upon UV treatment. Relative change in Pol II oc-
cupancy in the gene body is marked by yellow/
cyan-shaded (up/down) halos encompassing the
nodes. Gray indicates that a p53/RE was not as-
signed to these genes.
(B) Browser shot of the POLHgene, displaying UV-
induced p53 binding at an RE that contains a SNP
as a common variant. The lower panel displays a
blowup of the bound p53 RE, identifying the
location of the rs9333500 SNP at the seventh G
position.repair. RAD51 is reportedly p53 repressed (Arias-Lopez et al.,
2006), whereas we show here that RAD51C is induced, which
suggests differential usage of these recombinases during a
UV stress response. As such, this network regulates p53 itself,Cell Reports 8, 514–5the cell cycle, nucleotide excision repair,
and homologous DNA recombination
repair.
Another highly scored network regu-
lates cell death and survival, with 12 out
of the 22 genes in this network being
new p53 targets (Figure S7). Genes for
growth factors and their receptors, such
as FGFR2, VGF, PGF, and JAG1, were
identified. Notably, p53 may also directly
regulate FOSL1, encoding an AP1 family
transcription factor that was recently
discovered as a target of JQ1 in lung
cancer cells (Lockwood et al., 2012). As
shown in Figure 3, AP1 sites are also
positioned next to p53 sites. This repre-
sents a link of p53 with cell growth and
survival regulation. Genes with growth
inhibition functions were also identified,
such as DUSP7, BTG2, and BTG3. In
general, genes within this network regu-
late cell growth, cell death, and survival,
consistent with p53 being important in
maintaining tissue homeostasis after
DNA-damage recovery. The role of p53
in metabolism has been more recently
studied by Vousden and Prives (2009).
Within the metabolism network, 12 out
of the 17 genes were newly identified
p53 targets (Figure S7). These include
genes regulating RNA stability and
degradation (e.g., EXOSC4, DUSP11,
and PUM2), protein degradation (e.g.,
FBOX15 and FBOX22), and mito-
chondrial functions (e.g., COX6A1,MRPL36, and PANK2). Notably, PANK2 is a master regulator
of coenzyme A synthesis in mitochondria, the genetic alteration
of which is linked with neurodegenerative diseases (Zhou et al.,
2001).27, July 24, 2014 ª2014 The Authors 523
With a comprehensive and accurate map of p53-bound REs,
we sifted through the National Center for Biotechnology Informa-
tion (NCBI) dbSNP database (build 130 having 13,864,001 SNPs)
(Sherry et al., 2001) in search for any SNPs that overlappedwith a
p53 RE. We found one SNP (rs9333500) that was of particular in-
terest because it resided in a UV-inducible p53-bound RE that
we associated with the polH gene (Figure 7B). UV treatment re-
sulted in increased Pol II occupancy in the gene body of POLH.
This gene encodes the DNA-directed DNA Pol h and has been
reported to be upregulated by DNA damage in a p53-dependent
manner (Liu and Chen, 2006). polH conducts translesion DNA
synthesis through UV-induced pyrimidine dimers. Defects in
this gene result in xeroderma pigmentosum, displaying hyper-
mutability after exposure to UV irradiation and resulting in skin
malignancy (Loeb and Monnat, 2008; Masutani et al., 1999).
The rs9333500 SNP results in a change from G:C to T:A at posi-
tion 7. This is the ‘‘C’’ position in the RRRCW quarter site that is
internal to the RE, which is the least variable position within the
least variable quarter site. Surprisingly, the other quarter site
within the same half-site contained a nonconsensus ‘‘G’’ at po-
sition 4 (in RRRCW). Thus, this RE is expected to be intrinsically
weak and inducible. The rs9333500 SNP is expected to eliminate
p53 binding, altogether. rs9333500, which is homozygous in
2% of the human population (PDR90), is expected to render
these individuals sensitive to UV-induced DNA damage.
DISCUSSION
p53 Has a Single Predominant Mode of Binding across
the Human Genome
Our results point to the existence of about 2,200 p53/RE
complexes spread across the human genome, most of which
increase in occupancy in response to stress. ChIP-exo detects
p53/RE interactions as a triple peak pair pattern that may serve
as a useful diagnostic for p53 binding. We found no convincing
evidence for p53 binding to DNA sequences other than to a
20 bp unsplit RE that can have some degree of degeneracy,
based on the following reasoning and evidence. Putatively split
REs, having 2–13 bp spacers between two half-sites, may actu-
ally be degenerate unsplit sites that have one half-site below the
threshold of detection. Candidate p53 locations that we deemed
to be incorrect were infrequent and had low p53 occupancy and,
thus, were near the limits of detection. They lacked definitive
properties that include well-defined peaks and a well-defined
motif centered between peak pairs. Enrichedmotifs in their vicin-
ity were CT rich, making them similar to motifs enriched in so-
called ‘‘blacklisted’’ regions of the genome. Such regions tend
to give artifactual ChIP signals.
Stress caused increased binding of p53 to most REs, as
expected of the increased stability of p53. However, sites that
deviated the most from an RE consensus tended to have low
baseline occupancy of p53 and were more highly induced in
response to stress. Induced binding to weak sites may be
achieved in part through direct or indirect interactions of p53
with other proteins bound to motifs that are positionally con-
strained with respect to p53 REs. Many REs overlap by 10 bp,
whereas others are concentrated at about 250 bp apart. Taken
together, these findings paint p53 tetramers as a rather standard524 Cell Reports 8, 514–527, July 24, 2014 ª2014 The AuthorsDNA binding protein, having structurally stringent DNA binding
requirements, and with affinity modulated through variations in
DNA sequence. This comes as a surprising conclusion in light
of the multiple modes by which p53 has been reported to bind
DNA (el-Deiry et al., 1992; Funk et al., 1992; Riley et al., 2008).
We attribute the discrepancy to the ability of p53 to bind to
degenerate versions of its canonical site that fall below bio-
informatic detection but that may have a fortuitous innocuous
strong half-site consensus nearby.
RE-Linked Transcription Complexes
We could not definitively link 90% of all p53-bound REs to a
nearby ‘‘active’’ mRNA gene. Yet, most sit very close (<100 bp)
to where low levels of TFIIB and Pol II are detected, which we
interpret to be transcription initiation complexes. These p53-
associated transcription complexes tend to be stress induced
but depleted at high levels of p53. Because our data show that
p53-bound REs are often embedded within a complex panoply
of other stress-regulated transcription factor binding sites, we
further conjecture that local noncoding transcription units might
be regulated by such factors. Some of these ncRNAs might be
functionally important as structural RNAs and, thus, would be
expected to be more stable (perhaps polyadenylated and cap-
ped) (Djebali et al., 2012). Other RNAs may be irrelevant and
degraded as soon as they are made. Instead, the transcription
process itself may be important for example to alter the chro-
matin landscape.
A glimpse at one potential function came with our observa-
tion that many of the p53/RE-associated noncoding transcrip-
tion units reside in an antisense direction to stress-response
genes. Critical stress-response genes such as p21, PUMA,
and MDM2 appear to have this type of relationship. Just as
‘‘futile cycles’’ exist to simultaneously turn on and off enzymes,
offering more dynamic control, production of antisense tran-
scripts may in some cases function to downregulate the
expression of the coding sense transcripts. In such cases,
like at p21, both sense and antisense may be activated by
stress but antagonistic to each other. Regulation of transcrip-
tion in the antisense direction by p53 may therefore contribute
indirectly to the levels of the sense transcripts. p53 may also
function directly to activate the sense transcript, perhaps by
promoting release of a preassembled paused Pol II; although
from this study, we can only conclude that stress causes the
release of Pol II into gene bodies. Regardless of the mecha-
nism, the finding that many p53-activated genes are also asso-
ciated with antisense transcription raises the question as to the
extent to which p53 directly controls sense versus antisense
transcription.
p53 Permeates the Stress-Response Regulatory
Network
Our findings indicate that p53 may directly activate at least 151
annotated genes in U2OS cells in response to UV damage.
This number substantially exceeds known direct gene targets
of p53. The transcription machinery, as reflected by TFIIB and
a paused RNA Pol, is generally preassembled at the promoters
of these genes, wherein stress causes the release of paused
Pol II into an elongation competent state.
Although p53/RE interactions may regulate local noncoding
transcription, most p53/REs could not be linked directly to the
regulation of an active gene based on correlated responses to
UV treatment. However, those within 15 kb of a TSS or a preas-
sembled initiation complex could be reliably connected and form
the basis for a comprehensive p53 regulatory network. Addi-
tional p53-regulated genes likely exist but did not meet our
experimental criteria for activity and, thus, would be missed.
Somemay be latent targets that might be picked up in a different
cellular state.
In response to various upstream activation signals (e.g., DNA
damage), p53 is known to turn on the transcription of distinct
sets of target genes, which in turn regulate the cell cycle, cell
death, metabolism, and apoptosis (Ma, 2011; Vogelstein et al.,
2000; Vousden and Prives, 2009). In agreement with UV irradia-
tion inducingextensiveDNAdamages, p53 significantly activates
the DNA replication, recombination, and repair network genes.
Therefore, p53 appears to be an accurate sensor of various cell
stresses and appropriately activates the set of genes suitable
for the cell’s need. Strikingly, this network calls upon p53 target
genes involved in all steps of the DNA-damage repair, ranging
fromhalting thecell cycle, regenerating thecellular pools of deox-
ynucleotide triphosphates, and repairing DNAby both nucleotide
excision repair and homologous DNA recombination pathways.
Many feedback loops composed of p53 and its covalent
modification enzymes were found, indicating a fine-tuning of the
p53 function within this network. In addition, cell death and sur-
vival together with metabolism are the top gene networks
enrichedwithp53 targetgenesafterUV irradiation, demonstrating
that p53 coordinatesmultiple pathways in response to a stress. A
cell’s decision to live or die may be in part regulated by over 100
p53 target genes impinging on interconnected networks. Given
the complexity of the p53 network (Vousden and Prives, 2009),
future challenges lie with understanding how other signaling cas-
cades and stress-response transcription factors impinge upon
p53 regulation. The findings here and elsewhere hint at possible
roles for factors that recognize binding sites for the AP1,
GATA1, NRF2, FOXO3, and ETS/SPI1 family of transcription fac-
tors, as well as stem cell maintenance factors in modulating p53
activity via a direct physical relationship with p53 bound at an RE.
EXPERIMENTAL PROCEDURES
Cell Culture and Stress Treatment
U2OS and HCT116 cells were grown under standard conditions and treated
with one of the following stresses: 50 J/m2 of UV irradiation then cultured for
6 hr, 10 mM nutlin-3a for 6 hr, 1.6 mM doxorubicin for 6 hr, or 350 mM 5-fluorur-
acil for 6 hr. See also Supplemental Experimental Procedures.
ChIP-Exo
ChIP-exo experiments were carried out essentially as described with minor
alterations (Rhee and Pugh, 2012). RNA-seq was carried out on polyA+
selected RNA. Sequencing was performed using Applied Biosystems SOLiD
(for p53) and Illumina HiSeq 2000 (for p53, TFIIB, Pol II, and RNA). Uniquely
aligned tags were retained and filtered to remove those from heterochromatin
and so-called black-listed regions (provided by the ENCODE project).
Data Analysis
See Supplemental Experimental Procedures for additional details and ratio-
nale. The set of p53-occupied regions was defined as genomic intervals thatlacked a >60 bp gap of tags, and also had a reproducible peak pair as defined
in detail in the Supplemental Experimental Procedures. We searched for half-
site candidates (consensus RRRC4WWG7YYY) by allowing up to three
mismatches, except at the C4 or the G7 position, from 1,824 p53-occupied
regions identified in the merged UV-treated (0 and 6 hr) data set from U2OS
cells. Next, a search for a second half-site was performed but requiring that
any found half-site be 9–22 bp away (midpoint tomidpoint, or1 to 13 bp indel
between the half-sites), as justified by the literature. The second half-site was
allowed to include one mismatch at either the C4 or the G7 position, but not at
both. The total number of mismatches in the two half-sites (or full sites) could
not exceed seven. The reason that we chose seven as the limit is that the num-
ber of new RE instances fell to near zero at this limit. Only 19 of the top 1,000
occupied regions were at this limit (see Table S1). Only paired half-sites that
had at least one half-site with a reproducible tag count greater than zero on
each strand in the templated region (described under ‘‘Occupancy Determina-
tion’’ in the Supplemental Experimental Procedures) were called as p53
bound.
All potential candidates were screened over a 50 bp range centered to the
peak midpoint. Unsplit sites were chosen first in the bound region. If more
than one was found in a region, then the most highly occupied sites (up to
three) were chosen. Of these, the site with the strongest consensus was cho-
sen (Table S1; Figure 1A). If no unsplit site was found using the above criteria,
we then searched for split sites, giving priority to those with the shortest insert.
A total of 1,824 regions were grouped preliminarily into group 1P (n = 1,452)
and group 2P (n = 265), with the latter containing only those with 1 and
1–13 bp indels. Another 107 regions did not meet the RE criteria and were
designated as group 3. This preliminary group 1P set (n = 1,452) was used
in the binding sequence analysis shown in Figures 2A, 2B, S2A, and S2B.
Because an unsplit RE (i.e., two half-sites with no insertion) was the most
predominant species, and that the degeneracy of an RE might allow the
same motif to simultaneously appear as a split and an unsplit motif, we opted
for a second sweep through the initial group 2 set using MEME to identify any
overrepresented motif. An unsplit RE was returned (E = 1.6 3 1097). We then
applied this group 2 RE position-specific scoring matrix and FIMO (p < 103) to
group 2 and found 119 instances of unsplit REs. These were transferred to
group 1P (bottom set of Group 1 in Figure 1A) to make the final group 1 set
of 1,571 locations (U2OS, 0 and 6 hr UV) used in parts of this study. The
remaining 146 group 2 were subsequently analyzed in Figure S1C. Once
convinced that the full sites with ±1 bp indels may be valid REs, we subse-
quently transferred them to group 1 as part of Table S1 (although were kept
as part of group 2 in Figure 1A).
In addition, p53-bound regions were determined with other stress treat-
ments (nutlin-3a, 5-fluorouracil, and doxorubicin), and the finalized group 1
criteria, described above, were used to identify p53-bound REs in response
to these other stresses. These were added to the group 1 list to achieve a final
set of 2,183 p53-bound REs in Table S1. If a given p53-bound region had mul-
tiple REs bound by p53, only the strongest RE was included in Table S1.
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